These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 36362141)
41. Modified Shenlingbaizhu Decoction represses the pluripotency of colorectal cancer stem cells by inhibiting TGF-β mediated EMT program. Dai Y; Wang H; Sun R; Diao J; Ma Y; Shao M; Xu Y; Zhang Q; Gao Z; Zeng Z; Zhang L; Sun X Phytomedicine; 2022 Aug; 103():154234. PubMed ID: 35689903 [TBL] [Abstract][Full Text] [Related]
42. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis. Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092 [TBL] [Abstract][Full Text] [Related]
43. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis. Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942 [TBL] [Abstract][Full Text] [Related]
44. YAP promotes epithelial mesenchymal transition by upregulating Slug expression in human colorectal cancer cells. Cheng D; Jin L; Chen Y; Xi X; Guo Y Int J Clin Exp Pathol; 2020; 13(4):701-710. PubMed ID: 32355518 [TBL] [Abstract][Full Text] [Related]
45. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells. Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278 [No Abstract] [Full Text] [Related]
46. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance. Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111 [TBL] [Abstract][Full Text] [Related]
47. Jiedu Xiaozheng Yin extract targets cancer stem cells by Wnt signaling pathway in colorectal cancer. Feng H; Yang Y; Chen H; Zhang Z; Zeng J; Huang Y; Yang X; Yang L; Du J; Cao Z J Ethnopharmacol; 2025 Jan; 337(Pt 1):118710. PubMed ID: 39197803 [TBL] [Abstract][Full Text] [Related]
48. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways. Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957 [TBL] [Abstract][Full Text] [Related]
49. siRNA-induced CD44 knockdown suppresses the proliferation and invasion of colorectal cancer stem cells through inhibiting epithelial-mesenchymal transition. Zou W; Zhang Y; Bai G; Zhuang J; Wei L; Wang Z; Sun M; Wang J J Cell Mol Med; 2022 Apr; 26(7):1969-1978. PubMed ID: 35229451 [TBL] [Abstract][Full Text] [Related]
50. Role of cancer stem cells in racial disparity in colorectal cancer. Farhana L; Antaki F; Anees MR; Nangia-Makker P; Judd S; Hadden T; Levi E; Murshed F; Yu Y; Van Buren E; Ahmed K; Dyson G; Majumdar AP Cancer Med; 2016 Jun; 5(6):1268-78. PubMed ID: 26990997 [TBL] [Abstract][Full Text] [Related]
51. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702 [TBL] [Abstract][Full Text] [Related]
52. Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms. Avtanski D; Garcia A; Caraballo B; Thangeswaran P; Marin S; Bianco J; Lavi A; Poretsky L Cytokine; 2019 Aug; 120():155-164. PubMed ID: 31085453 [TBL] [Abstract][Full Text] [Related]
53. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700 [TBL] [Abstract][Full Text] [Related]
54. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1. Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669 [TBL] [Abstract][Full Text] [Related]
55. VX-509 attenuates the stemness characteristics of colorectal cancer stem-like cells by regulating the epithelial-mesenchymal transition through Nodal/Smad2/3 signaling. Yuan Y; Zhang XF; Li YC; Chen HQ; Wen T; Zheng JL; Zhao ZY; Hu QY World J Stem Cells; 2024 Feb; 16(2):207-227. PubMed ID: 38455101 [TBL] [Abstract][Full Text] [Related]
56. Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of β-catenin and Oct-4. Phiboonchaiyanan PP; Chanvorachote P Cell Oncol (Dordr); 2017 Oct; 40(5):497-510. PubMed ID: 28677037 [TBL] [Abstract][Full Text] [Related]
57. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells. Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731 [TBL] [Abstract][Full Text] [Related]
58. Pinocembrin Inhibits the Proliferation, Migration, Invasiveness, and Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Regulating LACTB. Jiang L; Yang Y; Feng H; Zhou Q; Liu Y Cancer Biother Radiopharm; 2022 Sep; 37(7):527-536. PubMed ID: 33395536 [No Abstract] [Full Text] [Related]
59. Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Fan F; Samuel S; Evans KW; Lu J; Xia L; Zhou Y; Sceusi E; Tozzi F; Ye XC; Mani SA; Ellis LM Cancer Med; 2012 Aug; 1(1):5-16. PubMed ID: 23342249 [TBL] [Abstract][Full Text] [Related]
60. 7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells. Cao X; Ren K; Song Z; Li D; Quan M; Zheng Y; Cao J; Zeng W; Zou H Oncol Rep; 2016 Aug; 36(2):1157-65. PubMed ID: 27279287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]